trial · primary record
Ribociclib
Early Breast Cancer
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 1466 |
| Primary completion | 2030-09-20 |
| Primary endpoint | Invasive Breast Cancer Free Survival (iBCFS) rate at 3 years |
| Registry ID | NCT05827081 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:56:15.505Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05827081
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.